Uslu R, Bonavida B
Department of Microbiology and Immunology, UCLA School of Medicine, University of California at Los Angeles 90095-1747, USA.
Cancer. 1996 Feb 15;77(4):725-32.
Previous studies have demonstrated that treatment of human tumor cell lines with a combination of cis-diamminedichloroplatinum (CDDP) and tumor necrosis factor-alpha (TNF-alpha) results in additive/synergistic cytotoxic effects and reverses tumor cell resistance to TNF drugs. Free radical intermediates are induced by both TNF-alpha and CDDP; however, the role of free radicals in synergy is not known. This study investigated the effect of two inhibitors on synergy, phenoxan (Phe) and butylated hydroxyanisole (BHA), which inhibit Complex I and Complex I and II of the mitochondrion respiratory chain, respectively.
Three human ovarian carcinoma cell lines of different sensitivity to TNF-alpha and/or CDDP were selected for the study and consisted of 222, a TNF/CDDP-sensitive line, 222TR (TNF-resistant), a TNF-resistant, CDDP-sensitive line, and AD10, a TNF-sensitive, CDDP-resistant line. Cytotoxicity was determined by the microculture tetrazolium dye assay.
Synergy in cytotoxicity was achieved in all three lines treated with a combination of TNF-alpha and CDDP. Cytotoxicity by either TNF-alpha or CDDP or by both TNF-alpha and CDDP was inhibited in the presence of either Phe or BHA. Pretreatment of tumor cells with either Phe or BHA for up to 4 hours, washed and followed by the addition of the cytotoxic agents (alone or combined), resulted in no inhibitory effect. Pretreatment of the cells with the cytotoxic agent for up to 2 hours, washed and then followed by the addition of Phe, resulted in significant inhibition of cytotoxicity. In contrast to Phe, the addition of BHA as late as 12 hours post pretreatment of the cells with the cytotoxic agent(s) still inhibited cytotoxicity. These results demonstrated that free radicals are involved in cytotoxicity mediated by a single agent, and in synergy with both agents. Further, the results demonstrated that Phe acts at an early stage of the cytotoxic pathway and that BHA acts at both an early and a late stage of the cytotoxic pathway.
These results demonstrated that both TNF-alpha and CDDP rapidly stimulate the induction of free radicals but a lag of several hours was necessary to initiate the irreversible program of cell death. Further, the studies demonstrated that synergy and reversal of drug resistance in ovarian tumor cells by TNF-alpha and CDDP, used in combination, share the same pathway of cytotoxicity as that mediated by TNF-alpha or CDDP used as a single agent.
先前的研究表明,用顺二氯二氨铂(CDDP)和肿瘤坏死因子-α(TNF-α)联合处理人肿瘤细胞系可产生相加/协同的细胞毒性作用,并逆转肿瘤细胞对TNF药物的耐药性。TNF-α和CDDP均可诱导自由基中间体产生;然而,自由基在协同作用中的作用尚不清楚。本研究调查了两种抑制剂苯氧嗪(Phe)和丁基羟基茴香醚(BHA)对协同作用的影响,它们分别抑制线粒体呼吸链的复合体I以及复合体I和II。
选择三种对TNF-α和/或CDDP敏感性不同的人卵巢癌细胞系进行研究,包括222(一种对TNF/CDDP敏感的细胞系)、222TR(对TNF耐药,对CDDP敏感的细胞系)和AD10(对TNF敏感,对CDDP耐药的细胞系)。通过微量培养四氮唑染料法测定细胞毒性。
用TNF-α和CDDP联合处理的所有三种细胞系均实现了细胞毒性的协同作用。在存在Phe或BHA的情况下,TNF-α或CDDP或两者联合的细胞毒性均受到抑制。用Phe或BHA对肿瘤细胞预处理长达4小时,洗涤后再加入细胞毒性药物(单独或联合使用),未产生抑制作用。用细胞毒性药物对细胞预处理长达2小时,洗涤后再加入Phe,可显著抑制细胞毒性。与Phe不同,在细胞用细胞毒性药物预处理后长达12小时添加BHA仍可抑制细胞毒性。这些结果表明,自由基参与了单一药物介导的细胞毒性作用以及两种药物的协同作用。此外,结果表明Phe作用于细胞毒性途径的早期,而BHA作用于细胞毒性途径的早期和晚期。
这些结果表明,TNF-α和CDDP均可迅速刺激自由基的产生,但需要数小时的延迟才能启动不可逆的细胞死亡程序。此外,研究表明,TNF-α和CDDP联合使用时,卵巢肿瘤细胞中的协同作用和耐药性逆转与单一使用TNF-α或CDDP介导的细胞毒性作用具有相同的途径。